Reimbursed with a limitationOriginator productATC C07AA05

Hemangiol

Hemangiol is an originator product from Pierre Fabre Pharma AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 192.40 to CHF 192.40 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Pierre Fabre Pharma AG
ATC code
C07AA05
IT group
02.03 Betablocker
Active substances
Propranololum
Preparation type
Originator product
On the SL since
01/11/2022
Last price change
01/12/2025
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Hemangiol Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Lös 3.75 mg/mlFl 120 mlCHF 161.83CHF 192.4001/11/2022B7680612140016

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/11/2022

Die Behandlung mit HEMANGIOL muss in Zentren, die über Erfahrung in Diagnose, Behandlung und Management des infantilen Hämangioms verfügen, in einem kontrollierten klinischen Umfeld mit angemessenen Einrichtungen zur Handhabung unerwünschter Reaktionen, einschliesslich solcher, die Notfallmassnahmen erfordern, initiiert werden.
HEMANGIOL wird zur Behandlung proliferativer infantiler Hämangiome, die eine systemische Therapie erfordern, vergütet.
Der Therapiebeginn ist bei Säuglingen zwischen 5 Wochen und 5 Monaten.
Die klinische Überwachung des Gesundheitszustands des Kindes sowie eine Neuanpassung der Dosis muss mindestens einmal pro Monat durchgeführt werden.
HEMANGIOL ist über einen Zeitraum von maximal 6 Monaten zu vergüten. Bei der Minderheit der Patienten, die nach Absetzen der Behandlung ein Rezidiv der Symptome zeigen, kann die Behandlung unter denselben Bedingungen erneut über einen Zeitraum von maximal 6 Monaten vergütet werden.

More preparations in this group

FAQ

Is Hemangiol covered by Swiss health insurance?

Yes, but only under conditions. Hemangiol is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Hemangiol cost in Switzerland?

The public price is the maximum price set by the FOPH and for Hemangiol ranges from CHF 192.40 to CHF 192.40 per pack. The ex-factory price ranges from CHF 161.83 to CHF 161.83. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com